By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Two archived webinars focus on the infectious disease consequences of the opioid crisis, highlighting national, federal, state, & community partners’ responses.
New research from the CDC suggests that the recent steep increase in cases of acute hepatitis C virus infection is associated with increases in opioid injection.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Organizations providing housing for the homeless can also be important sites for hepatitis C treatment and support.
By: Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
New tools can help communicate statistics on HIV, viral hepatitis, & opioid-related trends: amfAR’s Opioid & Health Indicators database and CDC’s AltasPlus.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
As part of the SAMHSA-sponsored HCV Current initiative, motivational interviewing video vignettes on HCV testing support provider-patient discussions on HCV testing.
By: Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services and Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
The HHS Office of HIV/AIDS and Infectious Disease Policy shares recent viral hepatitis developments & news items. The link(s) below may include nonfederal sites.
